|
2024
|
Invention
|
Cycloalkyl pyrimidines as ferroportin inhibitors.
The subject matter described herein is directe... |
|
|
Invention
|
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3... |
|
|
Invention
|
Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde... |
|
|
Invention
|
(s)-2-hydroxy-6-((4-(2-(2-hydroxyethyl)nicotinoyl)morpholin-3-yl)methoxy)benzaldehyd for use in t... |
|
2023
|
Invention
|
Solid forms of a modulator of hemoglobin.
Forms of (S)-2-hydroxy-6-((4-(2-(2-hydroxyethyl)nicoti... |
|
|
Invention
|
Cycloalkyl pyrimidines as ferroportin inhibitors. The subject matter described herein is directed... |
|
|
Invention
|
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation.
P... |
|
|
Invention
|
Process for preparation of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benz... |
|
2022
|
Invention
|
Methods of administering a modulator of hemoglobin.
Provided herein are methods for treating sic... |
|
|
Invention
|
Methods of administering a modulator of hemoglobin. Provided herein are methods for treating sick... |
|
|
Invention
|
Compounds and uses thereof for the modulation of hemoglobin.
Provide herein are compounds and ph... |
|
|
Invention
|
Methods of administering voxelotor. Provided herein are methods of using voxelotor for the treatm... |
|
|
Invention
|
Methods of treating sickle cell disease with voxelotor. Provided herein are methods of using voxe... |
|
|
Invention
|
Lactam pyrrolidine-pyrazoles as pyruvate kinase activators.
The subject matter described herein ... |
|
|
Invention
|
Lactam pyrrolidine-pyrazoles as pyruvate kinase activators. The subject matter described herein i... |
|
|
Invention
|
Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benza... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparatio... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
vaso-occlusive crisis; pharmaceutical preparati... |
|
|
Invention
|
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyd... |
|
|
Invention
|
Methods of making a modulator of hemoglobin. The present disclosure relates to processes for prep... |
|
|
Invention
|
Solid forms of a modulator of hemoglobin. Forms of (S)-2-hydroxy-6-((4-(2-(2-hydroxyethyl)nicotin... |
|
|
Invention
|
Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activators. The subject matter ... |
|
|
Invention
|
1-(2-sulfonyl-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4h)-yl]-ethanone derivatives as pyruvate kinase ... |
|
2021
|
Invention
|
1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde. The present disclosure relates to processes fo... |
|
|
Invention
|
Process for preparation of 2-hydroxy-6-((2-(1-isopropyl- 1h-pyrazol-5-yl)pyridin-3-yl)methoxy)ben... |
|
|
Invention
|
Azaindole compounds as histone methyltransferase inhibitors.
The present disclosure provides cer... |
|
|
Invention
|
Urea derivatives as pyruvate kinase activators.
The subject matter described herein is directed ... |
|
|
Invention
|
Urea derivatives as pyruvate kinase activators. The subject matter described herein is directed t... |
|
|
Invention
|
Methods of use for pyrimidines as ferroportin inhibitors.
The subject matter described herein is... |
|
|
Invention
|
Thieno pyrimidines as ferroportin inhibitors.
The subject matter described herein is directed to... |
|
|
Invention
|
Thieno pyrimidines as ferroportin inhibitors. The subject matter described herein is directed to ... |
|
|
Invention
|
Pyrrolidine-pyrazoles as pyruvate kinase activators.
The subject matter described herein is dire... |
|
|
Invention
|
Modulators of hemoglobin.
The present disclosure relates generally to compounds and pharmaceutic... |
|
2020
|
Invention
|
Methods of administering voxelotor.
Provided herein are methods of using voxelotor for the treat... |
|
|
P/S
|
Pharmacy referral services provided via a global computer
network; specialized retail pharmacy r... |
|
|
P/S
|
Pharmacy referral services provided via a global computer network; specialized retail pharmacy re... |
|
|
P/S
|
Pharmacy referral services provided via a global computer
network (terms too vague in the opinio... |
|
2019
|
P/S
|
Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell dise... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
hematological disorders such as sickle cell dis... |
|
2018
|
Invention
|
Tricyclic compounds as histone methyltransferase inhibitors. The present disclosure provides cert... |
|
2017
|
P/S
|
Pharmaceutical research and development services |
|
|
P/S
|
Downloadable computer software used to provide computerized adaptive tests regarding patient symp... |
|
2016
|
P/S
|
Pharmaceutical research and development services *, all of the aforementioned services not for u... |
